All Stories

  1. The Kir2.1-NaV1.5 Channelosome and its role in Arrhythmias in Inheritable Cardiac Diseases
  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
  3. SNTA1 Gene Rescues Ion Channel Function in Cardiomyocytes Derived from Induced Pluripotent Stem Cells Reprogrammed from Muscular Dystrophy Patients with Arrhythmias
  4. Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression
  5. Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
  6. Novel approaches to mechanism-based atrial fibrillation ablation
  7. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson–Gilford progeria syndrome
  8. Cardiac phenotype in familial partial lipodystrophy
  9. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome
  10. Anatomical targets and expected outcomes of catheter‐based ablation of atrial fibrillation in 2020
  11. Transcriptome and proteome mapping in the sheep atria reveal molecular featurets of atrial fibrillation progression
  12. Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents
  13. The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval
  14. Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death
  15. Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices
  16. Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association
  17. Mechanisms by Which Ranolazine Terminates Paroxysmal but Not Persistent Atrial Fibrillation
  18. Atrial Myopathy
  19. Instantaneous Amplitude and Frequency Modulations Detect the Footprint of Rotational Activity and Reveal Stable Driver Regions as Targets for Persistent Atrial Fibrillation Ablation
  20. A computational model of induced pluripotent stem‐cell derived cardiomyocytes incorporating experimental variability from multiple data sources
  21. Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors
  22. Lesion Index Titration Using Contact-Force Technology Enables Safe and Effective Radiofrequency Lesion Creation at the Root of the Aorta and Pulmonary Artery
  23. Clinical Characteristics and Electrophysiological Mechanisms Underlying Brugada ECG in Patients With Severe Hyperkalemia
  24. Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction
  25. Brugada syndrome trafficking–defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels
  26. Implications of bipolar voltage mapping and magnetic resonance imaging resolution in biventricular scar characterization after myocardial infarction
  27. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology
  28. Mechanisms and Drug Development in Atrial Fibrillation
  29. Cardiac Kir2.1 and Na V 1.5 Channels Traffic Together to the Sarcolemma to Control Excitability
  30. Factors affecting basket catheter detection of real and phantom rotors in the atria: A computational study
  31. The tornadoes of sudden cardiac arrest
  32. Causality analysis of leading singular value decomposition modes identifies rotor as the dominant driving normal mode in fibrillation
  33. Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development
  34. Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling
  35. Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule
  36. Synergistic Research Between the Center of Arrhythmia Research and the Michigan Biology of Cardiovascular Aging at the University of Michigan
  37. Triple threat: adiposity, aging, atrial fibrillation
  38. hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen
  39. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
  40. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
  41. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
  42. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
  43. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
  44. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary
  45. Propagation of Sinus Waves in the Atrial Architecture
  46. Is TGF-β 1 (Transforming Growth Factor-β 1 ) an Enabler of Myofibroblast–Cardiomyocyte Cross Talk?
  47. Selection of the Best of 2016 in Catheter Ablation
  48. Tbx20 controls the expression of the KCNH2 gene and of hERG channels
  49. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
  50. Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes
  51. Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro
  52. Dynamics and Molecular Mechanisms of Ventricular Fibrillation in Structurally Normal Hearts
  53. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication
  54. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production
  55. Constitutive Intracellular Na + Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia
  56. Atrial Fibrillation Susceptibility in Obesity
  57. Extracellular Matrix–Mediated Maturation of Human Pluripotent Stem Cell–Derived Cardiac Monolayer Structure and Electrophysiological Function
  58. Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes
  59. Mechanisms of Atrial Fibrillation
  60. Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation
  61. Pulmonary vein triggers, focal sources, rotors and atrial cardiomyopathy: implications for the choice of the most effective ablation therapy
  62. Structural and Functional Bases of Cardiac Fibrillation
  63. Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels
  64. Mechanistic Approaches to Detect, Target, and Ablate the Drivers of Atrial Fibrillation
  65. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria
  66. The elusive rotor electrogram footprint
  67. Letter by Jalife et al Regarding Article, “Quantitative Analysis of Localized Sources Identified by Focal Impulse and Rotor Modulation Mapping in Atrial Fibrillation”
  68. Ventricular Tachycardia and Early Fibrillation in Patients With Brugada Syndrome and Ischemic Cardiomyopathy Show Predictable Frequency-Phase Properties on the Precordial ECG Consistent With the Respective Arrhythmogenic Substrate
  69. Atrial remodeling, fibrosis, and atrial fibrillation
  70. Protein assemblies of sodium and inward rectifier potassium channels control cardiac excitability and arrhythmogenesis
  71. Ion Channel Macromolecular Complexes in Cardiomyocytes: Roles in Sudden Cardiac Death
  72. Spectral analysis-based risk score enables early prediction of mortality and cerebral performance in patients undergoing therapeutic hypothermia for ventricular fibrillation and comatose status
  73. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function
  74. A device for rapid and quantitative measurement of cardiac myocyte contractility
  75. Role of extracellular histones in the cardiomyopathy of sepsis
  76. Comparison of Radiofrequency Catheter Ablation of Drivers and Circumferential Pulmonary Vein Isolation in Atrial Fibrillation
  77. Spectral analysis of electrograms in a substrate modified by radiofrequency ablation reveals similarities between organized and disorganized atrial rhythms
  78. Mechanisms of Atrial Fibrillation
  79. Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation
  80. Scn1b deletion leads to increased tetrodotoxin‐sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts
  81. CrossTalk proposal: Rotors have been demonstrated to drive human atrial fibrillation
  82. Rebuttal from Sanjiv M. Narayan and José Jalife
  83. Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation
  84. Mechanisms of persistent atrial fibrillation
  85. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
  86. Modulated parasystole: Still relevant after all these years!
  87. And the beat goes on ... the beat goes on: organization and quasi-periodicity in ventricular fibrillation
  88. Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts
  89. Neuroanatomy of the murine cardiac conduction system
  90. Nerves projecting from the intrinsic cardiac ganglia of the pulmonary veins modulate sinoatrial node pacemaker function
  91. Noninvasive Localization of Maximal Frequency Sites of Atrial Fibrillation by Body Surface Potential Mapping
  92. Introduction to the Series on Computational Approaches to Cardiac Arrhythmias
  93. Mechanoelectric Feedback in the Ischemic Myocardium: An Interplay That Modulates Susceptibility to Fibrillation
  94. Rotors and the Dynamics of Cardiac Fibrillation
  95. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia
  96. Genetically Engineered Excitable Cardiac Myofibroblasts Coupled to Cardiomyocytes Rescue Normal Propagation and Reduce Arrhythmia Complexity in Heterocellular Monolayers
  97. TGF-β1, Released by Myofibroblasts, Differentially Regulates Transcription and Function of Sodium and Potassium Channels in Adult Rat Ventricular Myocytes
  98. Heterogeneity of Ryanodine Receptor Dysfunction in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
  99. The ionic bases of the action potential in isolated mouse cardiac Purkinje cell
  100. Long-Term Frequency Gradients During Persistent Atrial Fibrillation in Sheep Are Associated With Stable Sources in the Left Atrium
  101. Translational Research in Atrial Fibrillation
  102. Spatial gradients in action potential duration created by regional magnetofection of hERG are a substrate for wavebreak and turbulent propagation in cardiomyocyte monolayers
  103. Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells
  104. Elevated Pre-Operative Serum Peptides for Collagen I and III Synthesis Result in Post-Surgical Atrial Fibrillation
  105. Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update
  106. Biological pacemakers: The oscillatory road ahead
  107. High-rate pacing-induced atrial fibrillation effectively reveals properties of spontaneously occurring paroxysmal atrial fibrillation in humans
  108. Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte Monolayers
  109. Chloroquine Terminates Stretch-Induced Atrial Fibrillation More Effectively Than Flecainide in the Sheep Heart
  110. Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia
  111. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
  112. Radiofrequency catheter ablation of pulmonary vein roots results in axonal degeneration of distal epicardial nerves
  113. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A...
  114. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
  115. Optical Imaging of Voltage and Calcium in Cardiac Cells & Tissues
  116. Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit hearts
  117. Left-to-right ventricular differences in IKATP underlie epicardial repolarization gradient during global ischemia
  118. Time- and frequency-domain analyses of atrial fibrillation activation rate: The optical mapping reference
  119. Human Atrial Action Potential and Ca 2+ Model
  120. Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): Standardised reporting for model reproducibility, interoperability, and data sharing
  121. A null mutation of the neuronal sodium channel Na V 1.6 disrupts action potential propagation and excitation‐contraction coupling in the mouse heart
  122. Complex Fractionated Atrial Electrograms
  123. High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
  124. Guidance for the Heart Rhythm Society Pertaining to Interactions with Industry
  125. Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes
  126. Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations
  127. Mammalian enabled (Mena) is a critical regulator of cardiac function
  128. Structural heterogeneity promotes triggered activity, reflection and arrhythmogenesis in cardiomyocyte monolayers
  129. Complement dependency of cardiomyocyte release of mediators during sepsis
  130. Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart
  131. Left atrial pressure and dominant frequency of atrial fibrillation in humans
  132. Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine
  133. A Major Role for hERG in Determining Frequency of Reentry in Neonatal Rat Ventricular Myocyte Monolayer
  134. Deja vu in the theories of atrial fibrillation dynamics
  135. Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs
  136. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia
  137. Epicardial neural ganglionated plexus of ovine heart: Anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery
  138. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets
  139. Mechanisms Underlying the Antifibrillatory Action of Hyperkalemia in Guinea Pig Hearts
  140. Letter by Berenfeld and Jalife Regarding Article “Dominant Frequency of Atrial Fibrillation Correlates Poorly With Atrial Fibrillation Cycle Length”
  141. Inward rectifier potassium channels control rotor frequency in ventricular fibrillation
  142. Complex fractionated atrial electrograms: Properties of time-domain versus frequency-domain methods
  143. Left versus right atrial difference in dominant frequency, K+ channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery
  144. Paroxysmal atrioventricular block: Are phase 3 and phase 4 block mechanisms or misnomers?
  145. Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: Interplay between rotors and focal discharges
  146. A Single-Cell Model of Phase-Driven Control of Ventricular Fibrillation Frequency
  147. Prevention of Atrial Fibrillation
  148. Nerve Supply of the Human Pulmonary Veins: An Anatomical Study
  149. Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm
  150. Electrotonic Myofibroblast-to-Myocyte Coupling Increases Propensity to Reentrant Arrhythmias in Two-Dimensional Cardiac Monolayers
  151. Reentry in an accessory atrioventricular pathway as a trigger for atrial fibrillation initiation in manifest Wolff-Parkinson-White syndrome: A matter of reflection?
  152. RXP-E
  153. Atrial Septopulmonary Bundle of the Posterior Left Atrium Provides a Substrate for Atrial Fibrillation Initiation in a Model of Vagally Mediated Pulmonary Vein Tachycardia of the Structurally Normal Heart
  154. Role of Conduction Velocity Restitution and Short-Term Memory in the Development of Action Potential Duration Alternans in Isolated Rabbit Hearts
  155. Cardiac fibrillation: From ion channels to rotors in the human heart
  156. Universal scaling law of electrical turbulence in the mammalian heart
  157. Spatial Distribution of Fibrosis Governs Fibrillation Wave Dynamics in the Posterior Left Atrium During Heart Failure
  158. Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
  159. Three distinct phases of VF during global ischemia in the isolated blood-perfused pig heart
  160. Adenoviral Expression of I Ks Contributes to Wavebreak and Fibrillatory Conduction in Neonatal Rat Ventricular Cardiomyocyte Monolayers
  161. Endoscopic fluorescence mapping of the left atrium: A novel experimental approach for high resolution endocardial mapping in the intact heart
  162. Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans
  163. Reentry and atrial fibrillation
  164. Aging and atrial fibrillation research: Where we are and where we should go
  165. Up‐regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotors
  166. Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans
  167. Action Potential Duration Restitution Portraits of Mammalian Ventricular Myocytes: Role of Calcium Current
  168. Tiempo, espacio y frecuencia en la fibrilación ventricular
  169. Mechanisms of Wave Fractionation at Boundaries of High-Frequency Excitation in the Posterior Left Atrium of the Isolated Sheep Heart During Atrial Fibrillation
  170. Altered Right Atrial Excitation and Propagation in Connexin40 Knockout Mice
  171. Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans
  172. Ionic Determinants of Functional Reentry in a 2-D Model of Human Atrial Cells During Simulated Chronic Atrial Fibrillation
  173. Ionic mechanisms of wavebreak in fibrillation
  174. A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene
  175. Mechanisms of Atrial Fibrillation Termination by Pure Sodium Channel Blockade in an Ionically-Realistic Mathematical Model
  176. The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis
  177. Atrioventricular conduction in mammalian species: Hemodynamic and electrical scaling
  178. Effect of remodelling, stretch and ischaemia on ventricular fibrillation frequency and dynamics in a heart failure model
  179. From Mouse to Whale
  180. Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry
  181. Swapping Connexin Genes
  182. Cholinergic atrial fibrillation: IK,ACh gradients determine unequal left/right atrial frequencies and rotor dynamics
  183. Proceedings of the Third International Workshop on Computer Simulation and Experimental Assessment of Cardiac Electrical Function
  184. Synthesis of Voltage-Sensitive Fluorescence Signals from Three-Dimensional Myocardial Activation Patterns
  185. Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation
  186. Blockade of the Inward Rectifying Potassium Current Terminates Ventricular Fibrillation in the Guinea Pig Heart
  187. Wavebreak Formation During Ventricular Fibrillation in the Isolated, Regionally Ischemic Pig Heart
  188. WAVES IN EXCITABLE MEDIA: EFFECTS OF WAVE GEOMETRY
  189. Frequency-Dependent Breakdown of Wave Propagation Into Fibrillatory Conduction Across the Pectinate Muscle Network in the Isolated Sheep Right Atrium
  190. Minimal principle for rotor filaments
  191. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation
  192. Rectification of the Background Potassium Current
  193. New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias
  194. Standing Excitation Waves in the Heart Induced by Strong Alternating Electric Fields
  195. Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation
  196. Action Potential Characteristics and Arrhythmogenic Properties of the Cardiac Conduction System of the Murine Heart
  197. Null Mutation of Connexin43 Causes Slow Propagation of Ventricular Activation in the Late Stages of Mouse Embryonic Development
  198. Shaping of a scroll wave filament by cardiac fibers
  199. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart